| Vishal Gurung, | |
|
25 1st Ave Ne Ste 100, Buffalo, MN 55313-1598 | |
| (763) 682-3005 | |
| Not Available |
| Full Name | Vishal Gurung |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse |
| Location | 25 1st Ave Ne Ste 100, Buffalo, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043790512 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R-246714-0 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vishal Gurung, 25 1st Ave Ne Ste 100, Buffalo, MN 55313-1598 Ph: (763) 682-3005 | Vishal Gurung, 25 1st Ave Ne Ste 100, Buffalo, MN 55313-1598 Ph: (763) 682-3005 |
News Archive
A custody case in Texas has sparked heated debate and embroiled state policymakers in public discussions about the diagnosis and appropriate medical treatment of transgender children.
The Rasmussen Encephalitis (RE) Children's Project, a foundation that supports scientific research to find a cure for this devastating neurological disease, has donated $111,000 to researchers in the departments of neurosurgery and pathology/lab medicine (neuropathology) at Ronald Reagan UCLA Medical Center.
Patient Advocate Foundation - a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases - today released their annual Patient Data Analysis Report, which documents the scope and complexity of the healthcare finance, access and job retention issues routinely confronted by patients at the national and state-specific level.
Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.
Nanotechnology appears to be an unstoppable trend and it requires defined nanoscale building blocks and patterns.
› Verified 5 days ago
Mark Roy Harstad, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 206 Spruce Ave Ne, Buffalo, MN 55313 Phone: 763-333-6075 | |
Kathleen Carpentier, RN-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 1st Ave Ne, Buffalo, MN 55313 Phone: 763-682-3005 Fax: 763-682-3006 | |
John Friederichs Iii, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 1st Ave Ne Ste 100, Buffalo, MN 55313 Phone: 763-682-3005 | |
Josi Fjeld, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 1st Ave Ne Ste 100, Buffalo, MN 55313 Phone: 763-682-3005 | |
Tina Powers, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 915 6th Ave Ne Apt 301, Buffalo, MN 55313 Phone: 763-228-5658 | |
Chelsie Mauk, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 1st Ave Ne, Buffalo, MN 55313 Phone: 763-682-3005 |